The company said it will use the proceeds from the offering for general corporate and working capital purposes.
The firm said it intends to use net proceeds from the issuance of the notes for general corporate purposes.
The company said it will use the funds to develop antimicrobial therapeutics based on CRISPR-Cas3 technology.
The Salt Lake City-based company said it would use the $18.4 million in expected gross aggregate proceeds for product pipeline development and customer growth.
The firm privately negotiated the exchange with current holders of convertible notes due 2017.
Quidel will use the net proceeds from the offering for working capital and other general corporate purposes.
PositiveID will issue $4 million in senior secured convertible promissory notes to institutional investor Dominion Capital, the firm announced today.
NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Wednesday that it successfully completed the previously announced repurchase of convertible notes due in 2026 and the issuance
NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Monday that it has given notice of its intention to redeem all of its outstanding 3.50 percent senior convertible notes due 2038.
By a GenomeWeb staff reporter
Cancer researcher Alan Rabson has died at 92, the New York Times reports.
As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.
In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.
The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.